1. Home
  2. RDWR vs EVO Comparison

RDWR vs EVO Comparison

Compare RDWR & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDWR
  • EVO
  • Stock Information
  • Founded
  • RDWR 1996
  • EVO 1993
  • Country
  • RDWR Israel
  • EVO Germany
  • Employees
  • RDWR N/A
  • EVO N/A
  • Industry
  • RDWR EDP Services
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • RDWR Technology
  • EVO Health Care
  • Exchange
  • RDWR Nasdaq
  • EVO Nasdaq
  • Market Cap
  • RDWR 1.1B
  • EVO 1.2B
  • IPO Year
  • RDWR 1999
  • EVO 2021
  • Fundamental
  • Price
  • RDWR $25.01
  • EVO $3.48
  • Analyst Decision
  • RDWR Hold
  • EVO Buy
  • Analyst Count
  • RDWR 3
  • EVO 2
  • Target Price
  • RDWR $32.50
  • EVO $5.40
  • AVG Volume (30 Days)
  • RDWR 153.7K
  • EVO 52.1K
  • Earning Date
  • RDWR 10-30-2025
  • EVO 11-05-2025
  • Dividend Yield
  • RDWR N/A
  • EVO N/A
  • EPS Growth
  • RDWR N/A
  • EVO N/A
  • EPS
  • RDWR 0.32
  • EVO N/A
  • Revenue
  • RDWR $288,813,000.00
  • EVO $912,894,891.00
  • Revenue This Year
  • RDWR $11.14
  • EVO $0.43
  • Revenue Next Year
  • RDWR $7.27
  • EVO $9.72
  • P/E Ratio
  • RDWR $78.28
  • EVO N/A
  • Revenue Growth
  • RDWR 11.51
  • EVO N/A
  • 52 Week Low
  • RDWR $18.46
  • EVO $2.84
  • 52 Week High
  • RDWR $31.57
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • RDWR 45.69
  • EVO 39.61
  • Support Level
  • RDWR $24.42
  • EVO $3.36
  • Resistance Level
  • RDWR $26.08
  • EVO $3.58
  • Average True Range (ATR)
  • RDWR 0.61
  • EVO 0.08
  • MACD
  • RDWR 0.10
  • EVO -0.00
  • Stochastic Oscillator
  • RDWR 42.47
  • EVO 31.58

About RDWR Radware Ltd.

Radware Ltd provides cyber security and application delivery solutions. The company provides solutions for cloud, on-premises, and software-defined data centers (SDDC). The solutions of the company secure the digital experience by providing infrastructure, application, and network protection and availability services to enterprises globally. The business segments of the company are Radware's Core Business and The Hawks' Business. The company derives maximum revenue from Radware's Core Business. It generates the majority of its revenue from the United States.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: